vs
AYTU BIOPHARMA, INC（AYTU）与Digimarc CORP（DMRC）财务数据对比。点击上方公司名可切换其他公司
AYTU BIOPHARMA, INC的季度营收约是Digimarc CORP的1.7倍（$15.2M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -69.8%，领先22.6%），Digimarc CORP同比增速更快（2.9% vs -6.5%），AYTU BIOPHARMA, INC自由现金流更多（$3.7M vs $895.0K），过去两年AYTU BIOPHARMA, INC的营收复合增速更高（4.0% vs -5.3%）
AYTU生物制药是一家总部位于美国的特种制药企业，研发并商业化消费级健康产品与处方治疗药物，产品线覆盖感冒过敏用药、生殖健康解决方案及罕见儿科疾病治疗药物，服务美国本土患者与医疗服务提供者。
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
AYTU vs DMRC — 直观对比
营收规模更大
AYTU
是对方的1.7倍
$8.9M
营收增速更快
DMRC
高出9.4%
-6.5%
净利率更高
DMRC
高出22.6%
-69.8%
自由现金流更多
AYTU
多$2.8M
$895.0K
两年增速更快
AYTU
近两年复合增速
-5.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.2M | $8.9M |
| 净利润 | $-10.6M | $-4.2M |
| 毛利率 | 63.5% | 63.5% |
| 营业利润率 | -13.0% | -48.2% |
| 净利率 | -69.8% | -47.2% |
| 营收同比 | -6.5% | 2.9% |
| 净利润同比 | -1443.1% | 51.4% |
| 每股收益（稀释后） | $-1.05 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AYTUDMRC
| Q4 25 | $15.2M | $8.9M | ||
| Q3 25 | $13.9M | $7.6M | ||
| Q2 25 | $15.1M | $8.0M | ||
| Q1 25 | $18.5M | $9.4M | ||
| Q4 24 | $16.2M | $8.7M | ||
| Q3 24 | $16.6M | $9.4M | ||
| Q2 24 | $14.6M | $10.4M | ||
| Q1 24 | $14.0M | $9.9M |
净利润AYTUDMRC
| Q4 25 | $-10.6M | $-4.2M | ||
| Q3 25 | $2.0M | $-8.2M | ||
| Q2 25 | $-19.8M | $-8.2M | ||
| Q1 25 | $4.0M | $-11.7M | ||
| Q4 24 | $788.0K | $-8.6M | ||
| Q3 24 | $1.5M | $-10.8M | ||
| Q2 24 | $-4.6M | $-9.3M | ||
| Q1 24 | $-2.9M | $-10.3M |
毛利率AYTUDMRC
| Q4 25 | 63.5% | 63.5% | ||
| Q3 25 | 66.1% | 58.3% | ||
| Q2 25 | 67.8% | 58.8% | ||
| Q1 25 | 69.4% | 65.0% | ||
| Q4 24 | 66.5% | 60.8% | ||
| Q3 24 | 72.3% | 62.4% | ||
| Q2 24 | 75.7% | 66.1% | ||
| Q1 24 | 73.9% | 62.5% |
营业利润率AYTUDMRC
| Q4 25 | -13.0% | -48.2% | ||
| Q3 25 | -10.8% | -109.7% | ||
| Q2 25 | -50.4% | -105.2% | ||
| Q1 25 | 13.1% | -128.9% | ||
| Q4 24 | -10.4% | -105.1% | ||
| Q3 24 | -5.6% | -120.4% | ||
| Q2 24 | -15.6% | -96.2% | ||
| Q1 24 | -11.4% | -109.2% |
净利率AYTUDMRC
| Q4 25 | -69.8% | -47.2% | ||
| Q3 25 | 14.1% | -106.9% | ||
| Q2 25 | -130.9% | -102.6% | ||
| Q1 25 | 21.6% | -125.2% | ||
| Q4 24 | 4.9% | -99.9% | ||
| Q3 24 | 8.9% | -113.9% | ||
| Q2 24 | -31.6% | -89.3% | ||
| Q1 24 | -20.6% | -104.0% |
每股收益（稀释后）AYTUDMRC
| Q4 25 | $-1.05 | $-0.18 | ||
| Q3 25 | $-0.08 | $-0.38 | ||
| Q2 25 | — | $-0.38 | ||
| Q1 25 | $0.21 | $-0.55 | ||
| Q4 24 | $-0.26 | $-0.40 | ||
| Q3 24 | $-0.15 | $-0.50 | ||
| Q2 24 | — | $-0.43 | ||
| Q1 24 | $-0.52 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.0M | $12.9M |
| 总债务越低越好 | $10.0M | — |
| 股东权益账面价值 | $14.2M | $40.2M |
| 总资产 | $122.0M | $53.0M |
| 负债/权益比越低杠杆越低 | 0.70× | — |
8季度趋势，按日历期对齐
现金及短期投资AYTUDMRC
| Q4 25 | $30.0M | $12.9M | ||
| Q3 25 | $32.6M | $12.6M | ||
| Q2 25 | $31.0M | $16.1M | ||
| Q1 25 | $18.2M | $21.6M | ||
| Q4 24 | $20.4M | $28.7M | ||
| Q3 24 | $20.1M | $33.7M | ||
| Q2 24 | $20.0M | $41.5M | ||
| Q1 24 | $19.8M | $48.9M |
总债务AYTUDMRC
| Q4 25 | $10.0M | — | ||
| Q3 25 | $10.4M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $9.5M | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $10.9M | — | ||
| Q1 24 | $0 | — |
股东权益AYTUDMRC
| Q4 25 | $14.2M | $40.2M | ||
| Q3 25 | $23.2M | $41.4M | ||
| Q2 25 | $19.0M | $46.5M | ||
| Q1 25 | $34.9M | $50.0M | ||
| Q4 24 | $30.8M | $61.4M | ||
| Q3 24 | $29.8M | $70.2M | ||
| Q2 24 | $27.7M | $77.2M | ||
| Q1 24 | $30.8M | $84.5M |
总资产AYTUDMRC
| Q4 25 | $122.0M | $53.0M | ||
| Q3 25 | $125.0M | $55.4M | ||
| Q2 25 | $124.2M | $60.7M | ||
| Q1 25 | $124.2M | $66.5M | ||
| Q4 24 | $116.2M | $75.8M | ||
| Q3 24 | $115.8M | $85.0M | ||
| Q2 24 | $118.1M | $93.4M | ||
| Q1 24 | $128.9M | $99.7M |
负债/权益比AYTUDMRC
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.35× | — | ||
| Q2 24 | 0.39× | — | ||
| Q1 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.7M | $991.0K |
| 自由现金流经营现金流 - 资本支出 | $3.7M | $895.0K |
| 自由现金流率自由现金流/营收 | 24.1% | 10.0% |
| 资本支出强度资本支出/营收 | 0.1% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-12.3M |
8季度趋势，按日历期对齐
经营现金流AYTUDMRC
| Q4 25 | $3.7M | $991.0K | ||
| Q3 25 | $-618.0K | $-2.6M | ||
| Q2 25 | $2.8M | $-4.7M | ||
| Q1 25 | $-6.5M | $-5.5M | ||
| Q4 24 | $2.9M | $-4.2M | ||
| Q3 24 | $-1.2M | $-7.1M | ||
| Q2 24 | $-788.0K | $-6.8M | ||
| Q1 24 | $-254.0K | $-8.4M |
自由现金流AYTUDMRC
| Q4 25 | $3.7M | $895.0K | ||
| Q3 25 | — | $-2.8M | ||
| Q2 25 | — | $-4.9M | ||
| Q1 25 | $-6.5M | $-5.5M | ||
| Q4 24 | $2.9M | $-4.2M | ||
| Q3 24 | $-1.3M | $-7.2M | ||
| Q2 24 | — | $-6.9M | ||
| Q1 24 | — | $-8.5M |
自由现金流率AYTUDMRC
| Q4 25 | 24.1% | 10.0% | ||
| Q3 25 | — | -36.9% | ||
| Q2 25 | — | -61.0% | ||
| Q1 25 | -35.4% | -59.1% | ||
| Q4 24 | 17.9% | -49.1% | ||
| Q3 24 | -8.0% | -75.7% | ||
| Q2 24 | — | -66.1% | ||
| Q1 24 | — | -85.8% |
资本支出强度AYTUDMRC
| Q4 25 | 0.1% | 1.1% | ||
| Q3 25 | 0.0% | 2.9% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.8% | 0.7% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | 0.0% | 1.1% |
现金转化率AYTUDMRC
| Q4 25 | — | — | ||
| Q3 25 | -0.31× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -1.62× | — | ||
| Q4 24 | 3.69× | — | ||
| Q3 24 | -0.81× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AYTU
暂无分部数据
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
